Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis.

Velasquez, W S

Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis. [electronic resource] - Cancer May 1994 - 2408-16 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.

0008-543X

10.1002/1097-0142(19940501)73:9<2408::aid-cncr2820730926>3.0.co;2-m doi


Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Bleomycin--administration & dosage
Combined Modality Therapy
Cyclophosphamide--administration & dosage
Dexamethasone--administration & dosage
Doxorubicin--administration & dosage
Etoposide--administration & dosage
Female
Follow-Up Studies
Humans
L-Lactate Dehydrogenase--blood
Lymphoma, Non-Hodgkin--drug therapy
Male
Methotrexate--administration & dosage
Middle Aged
Prednisone--administration & dosage
Prognosis
Radiotherapy Dosage
Remission Induction
Survival Rate
Vincristine--administration & dosage
beta 2-Microglobulin--analysis